Home
Conditions
Hepatocellular Carcinoma

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Not Yet Recruiting

Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

NCT07365839

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Not Yet Recruiting

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

NCT07368023

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Ningbo Medical Centre Lihuili Hospital Ningbo, Zhejiang, China

View Trial Details

Not Yet Recruiting

MR 7700 Multinuclear Application Clinical Study

NCT07368049

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

NCT07356037

Conditions: Adenocarcinoma, Body Weight, Body Weight Changes, +16 more
Locations: West China School of Medicine/West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

NCT07341321

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Medical University of Graz Graz, Austria

Ordensklinikum Linz Linz, Austria

University Hospital St. Pölten Sankt Pölten, Austria

Krankenhaus der Barmherzigen Brüder St Veit an der Glan Sankt Veit an der Glan, Austria

View Trial Details

Not Yet Recruiting

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT07309419

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

NCT07310836

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

NCT07281664

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

NCT07179900

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules

NCT07272083

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italia Roma, Italy

View Trial Details

Hepatocellular Carcinoma

Hepatocellular Carcinoma trial results

Related conditions